Literature DB >> 30314603

Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease.

Andreas-Antonios Roussakis1, Paola Piccini2.   

Abstract

Neuroinflammation is an important aspect of Parkinson's disease. The study of Parkinson's disease neuroinflammation is quite challenging and is accompanied by controversy. To date, molecular imaging studies have been targeting microglia and more recently astrocytes. In this review article, we discuss the findings from key PET studies with tracers specific for the translocator protein (microglia-specific) and novel evidence from the development of astrocyte-specific PET tracers. We also discuss evidence from pathology studies and in the animal model of Parkinson's disease that form the biological background of current and newer PET neuroinflammation tracers. However, findings from PET imaging studies in microglia have so far not been translated in clinical practice, while no PET study has been conducted in Parkinson's disease specifically targeting astrocytes. Research work is currently focused on (a) identifying new molecular targets for the study of neuroinflammation through PET, (b) assessing the state of neuroinflammation in Parkinson's disease with accuracy and reliability, and (c) developing strategies to modulate the underlying processes of neuroinflammation.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activated state; Astrocytes; I2BS; Microglia; Neuroinflammation; PET; Translocator protein

Mesh:

Substances:

Year:  2018        PMID: 30314603     DOI: 10.1016/bs.irn.2018.08.009

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  4 in total

1.  iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson's Disease.

Authors:  Katja Badanjak; Patrycja Mulica; Semra Smajic; Sylvie Delcambre; Leon-Charles Tranchevent; Nico Diederich; Thomas Rauen; Jens C Schwamborn; Enrico Glaab; Sally A Cowley; Paul M A Antony; Sandro L Pereira; Carmen Venegas; Anne Grünewald
Journal:  Front Cell Dev Biol       Date:  2021-11-05

2.  Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with 11C-BU99008 PET.

Authors:  Mohamed A Mohamed; Zhou Zeng; Marta Gennaro; Nicholas P Lao-Kaim; Jim F M Myers; Valeria Calsolaro; Grazia Daniela Femminella; Robin J Tyacke; Antonio Martin-Bastida; Roger N Gunn; David J Nutt; Paul Edison; Paola Piccini; Andreas-Antonios Roussakis
Journal:  Brain Commun       Date:  2022-08-18

Review 3.  Parkinson disease and the immune system - associations, mechanisms and therapeutics.

Authors:  Eng-King Tan; Yin-Xia Chao; Andrew West; Ling-Ling Chan; Werner Poewe; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2020-04-24       Impact factor: 42.937

4.  Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [18F]FEPPA.

Authors:  Nicolas Vignal; Anne-Cécile Boulay; Carine San; Martine Cohen-Salmon; Nathalie Rizzo-Padoin; Laure Sarda-Mantel; Xavier Declèves; Salvatore Cisternino; Benoît Hosten
Journal:  Cells       Date:  2020-02-07       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.